Artal Group as of March 31, 2018
Portfolio Holdings for Artal Group
Artal Group holds 102 positions in its portfolio as reported in the March 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Blue Buffalo Pet Prods | 43.6 | $3.5B | 88M | 39.81 | |
Weight Watchers International | 23.5 | $1.9B | 29M | 63.72 | |
Lexicon Pharmaceuticals (LXRX) | 6.2 | $499M | 58M | 8.57 | |
Spdr S&p 500 Etf (SPY) | 1.6 | $132M | 500k | 263.15 | |
Bank of America Corporation (BAC) | 1.6 | $131M | 4.4M | 29.99 | |
General Motors Company (GM) | 1.6 | $127M | 3.5M | 36.34 | |
Beigene (BGNE) | 1.3 | $101M | 600k | 168.00 | |
Nektar Therapeutics (NKTR) | 1.2 | $96M | 900k | 106.26 | |
International Business Machines (IBM) | 1.1 | $92M | 600k | 153.43 | |
Goldman Sachs (GS) | 1.1 | $88M | 350k | 251.86 | |
Exxon Mobil Corporation (XOM) | 0.9 | $75M | 1.0M | 74.61 | |
Incyte Corporation (INCY) | 0.9 | $71M | 850k | 83.33 | |
Alnylam Pharmaceuticals (ALNY) | 0.9 | $72M | 600k | 119.10 | |
Wells Fargo & Company (WFC) | 0.8 | $68M | 1.3M | 52.41 | |
Celgene Corporation | 0.7 | $58M | 650k | 89.21 | |
Chevron Corporation (CVX) | 0.7 | $57M | 500k | 114.04 | |
Bristol Myers Squibb (BMY) | 0.7 | $57M | 900k | 63.25 | |
Amicus Therapeutics (FOLD) | 0.6 | $51M | 3.4M | 15.04 | |
Atara Biotherapeutics (ATRA) | 0.6 | $49M | 1.3M | 39.00 | |
Blueprint Medicines (BPMC) | 0.6 | $46M | 500k | 91.70 | |
Agios Pharmaceuticals (AGIO) | 0.6 | $45M | 550k | 81.78 | |
SPDR S&P Biotech (XBI) | 0.6 | $44M | 500k | 87.73 | |
Tesaro | 0.5 | $43M | 750k | 57.14 | |
Acceleron Pharma | 0.4 | $33M | 850k | 39.10 | |
Array BioPharma | 0.4 | $33M | 2.0M | 16.32 | |
Caterpillar (CAT) | 0.4 | $30M | 200k | 147.38 | |
Medicines Company | 0.4 | $30M | 900k | 32.94 | |
Bluebird Bio (BLUE) | 0.3 | $26M | 150k | 170.75 | |
Avexis | 0.2 | $20M | 160k | 123.58 | |
Anaptysbio Inc Common (ANAB) | 0.2 | $20M | 190k | 104.08 | |
Regeneron Pharmaceuticals (REGN) | 0.2 | $17M | 50k | 344.36 | |
Freeport-McMoRan Copper & Gold (FCX) | 0.2 | $18M | 1.0M | 17.57 | |
Albireo Pharma | 0.2 | $18M | 548k | 32.57 | |
Alexion Pharmaceuticals | 0.2 | $17M | 150k | 111.46 | |
BioMarin Pharmaceutical (BMRN) | 0.2 | $16M | 200k | 81.07 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.2 | $16M | 100k | 162.98 | |
Sage Therapeutics (SAGE) | 0.2 | $16M | 100k | 161.07 | |
Clovis Oncology | 0.2 | $13M | 250k | 52.80 | |
Agenus (AGEN) | 0.2 | $13M | 2.8M | 4.71 | |
Argenx Se (ARGX) | 0.1 | $12M | 150k | 80.44 | |
Iqiyi (IQ) | 0.1 | $12M | 750k | 15.55 | |
Accelr8 Technology | 0.1 | $11M | 500k | 22.85 | |
Fibrogen (FGEN) | 0.1 | $12M | 250k | 46.20 | |
Radius Health | 0.1 | $11M | 300k | 35.94 | |
Global Blood Therapeutics In | 0.1 | $9.7M | 200k | 48.30 | |
La Jolla Pharmaceuticl Com Par | 0.1 | $8.9M | 300k | 29.78 | |
Xencor (XNCR) | 0.1 | $9.0M | 300k | 29.98 | |
Zafgen | 0.1 | $8.9M | 1.2M | 7.45 | |
Denali Therapeutics (DNLI) | 0.1 | $8.9M | 450k | 19.69 | |
Neurocrine Biosciences (NBIX) | 0.1 | $8.3M | 100k | 82.93 | |
Fate Therapeutics (FATE) | 0.1 | $8.3M | 850k | 9.76 | |
Zogenix | 0.1 | $8.0M | 200k | 40.05 | |
Iovance Biotherapeutics (IOVA) | 0.1 | $7.8M | 460k | 16.90 | |
Vital Therapies | 0.1 | $6.8M | 1.0M | 6.80 | |
Regenxbio Inc equity us cm (RGNX) | 0.1 | $7.5M | 250k | 29.85 | |
D Stemline Therapeutics | 0.1 | $6.1M | 400k | 15.30 | |
Wave Life Sciences (WVE) | 0.1 | $6.0M | 150k | 40.10 | |
Ac Immune Sa (ACIU) | 0.1 | $6.2M | 600k | 10.34 | |
Glycomimetics (GLYC) | 0.1 | $5.3M | 325k | 16.23 | |
Cymabay Therapeutics (CBAY) | 0.1 | $5.2M | 400k | 12.99 | |
Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $5.9M | 1.9M | 3.08 | |
Madrigal Pharmaceuticals (MDGL) | 0.1 | $5.3M | 45k | 116.80 | |
Idera Pharmaceuticals | 0.1 | $5.1M | 2.8M | 1.84 | |
Akebia Therapeutics (AKBA) | 0.1 | $4.5M | 475k | 9.53 | |
Dynavax Technologies (DVAX) | 0.1 | $5.0M | 250k | 19.85 | |
Aduro Biotech | 0.1 | $5.1M | 550k | 9.30 | |
Audentes Therapeutics | 0.1 | $4.5M | 150k | 30.05 | |
Spero Therapeutics (SPRO) | 0.1 | $5.0M | 350k | 14.25 | |
Rocket Pharmaceuticals (RCKT) | 0.1 | $4.7M | 250k | 18.75 | |
Arcus Biosciences Incorporated (RCUS) | 0.1 | $4.6M | 300k | 15.44 | |
Novagold Resources Inc Cad (NG) | 0.1 | $4.3M | 1.0M | 4.33 | |
Dicerna Pharmaceuticals | 0.1 | $4.1M | 425k | 9.56 | |
Synlogic | 0.1 | $3.8M | 400k | 9.38 | |
Inflarx Nv (IFRX) | 0.1 | $3.6M | 125k | 28.84 | |
Restorbio | 0.1 | $4.3M | 450k | 9.58 | |
Sangamo Biosciences (SGMO) | 0.0 | $2.9M | 150k | 19.00 | |
Ironwood Pharmaceuticals (IRWD) | 0.0 | $3.3M | 217k | 15.43 | |
Tg Therapeutics (TGTX) | 0.0 | $3.6M | 250k | 14.20 | |
Portola Pharmaceuticals | 0.0 | $3.3M | 100k | 32.66 | |
Miragen Therapeutics | 0.0 | $3.5M | 500k | 7.01 | |
Clementia | 0.0 | $3.0M | 200k | 15.15 | |
Achillion Pharmaceuticals | 0.0 | $2.8M | 750k | 3.71 | |
Chimerix (CMRX) | 0.0 | $2.6M | 500k | 5.20 | |
Syndax Pharmaceuticals (SNDX) | 0.0 | $2.1M | 150k | 14.23 | |
Adverum Biotechnologies (ADVM) | 0.0 | $2.3M | 400k | 5.80 | |
Marinus Pharmaceuticals | 0.0 | $1.9M | 500k | 3.82 | |
Minerva Neurosciences | 0.0 | $1.9M | 300k | 6.25 | |
Atyr Pharma Inc Common Stock Usd 0.001 | 0.0 | $1.3M | 500k | 2.65 | |
Kura Oncology (KURA) | 0.0 | $1.9M | 100k | 18.75 | |
Intellia Therapeutics (NTLA) | 0.0 | $1.9M | 90k | 21.09 | |
Selecta Biosciences (RNAC) | 0.0 | $1.3M | 125k | 10.19 | |
Krystal Biotech (KRYS) | 0.0 | $1.5M | 150k | 10.09 | |
Homology Medicines (FIXX) | 0.0 | $1.9M | 100k | 18.70 | |
Novavax | 0.0 | $1.1M | 500k | 2.10 | |
Xenon Pharmaceuticals (XENE) | 0.0 | $735k | 150k | 4.90 | |
Trillium Therapeutics, Inc. Cmn | 0.0 | $1.1M | 150k | 7.20 | |
Editas Medicine (EDIT) | 0.0 | $829k | 25k | 33.16 | |
Crispr Therapeutics (CRSP) | 0.0 | $1.1M | 25k | 45.72 | |
Noveliontherapeuti.. | 0.0 | $897k | 256k | 3.50 | |
Tocagen | 0.0 | $1.2M | 100k | 11.85 | |
Solid Biosciences | 0.0 | $1.1M | 150k | 7.50 | |
Oncocyte | 0.0 | $315k | 150k | 2.10 |